<
>
Welcome to Amphastar
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing:
• Injectable, intranasal, and inhalation products;
• Complex medication including biologics that are derived from living cells or organisms, proteins, and interchangeable biosimilars;
• Various innovative drug delivery systems for different routes of administration; and
• Various proprietary products and technological platforms.
BAQSIMI®: The #1 PRESCRIBED GLUCAGON IN THE US1
The First And Only Dry Nasal Spray to Treat Very Low Blood Sugar
(Glucagon) Nasal Powder 3mg
1 Data on File. Amphastar Pharmaceuticals, Inc.
Iron Sucrose Injection, USP
50mg/2.5mL, 100mg/5mL, and 200mg/10mL Single-dose vials: Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD).
560 mcg/2.24 mL (250 mcg/mL) in a single-patient- use prefilled delivery device (pen) intended to deliver 28 daily doses of 20 mcg.
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
International Medication Systems, Ltd., a subsidiary of Amphastar Pharmaceuticals, Inc. received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. This prestigious award recognizes IMS significant efforts in preventing and alleviating critical drug shortages, ensuring that patients have access to essential medications.
Copyright © 2026 Amphastar Pharmaceuticals, Inc.
This site is intended for residents of the United States